Hematocytometry analysis as discriminative marker for asthma phenotypes

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 5, 2009, Pages 573-578

  Velthove, Karin J ^a,b   Van Solinge, Wouter W ^a,b   Lammers, Jan Willem J ^b   Leufkens, Hubert G M ^a   Schweizer, René C ^b   Bracke, Madelon ^a,b,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c XPand Biotechnology BV   (Netherlands)

Author keywords

Asthma; Biomarkers; Hematocytometry; Morphology; Neutrophils

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; ASTHMA; BLOOD SAMPLING; CELL STRUCTURE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOMETRY; FEMALE; HEMATOCYTOMETRY; HEMATOLOGICAL PARAMETERS; HUMAN; LEUKOCYTE; LEUKOCYTE COUNT; LOGISTIC REGRESSION ANALYSIS; MALE; NEUTROPHIL; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; ASTHMA; CELL SIZE; FEMALE; HEMATOLOGIC TESTS; HUMANS; LEUKOCYTE COUNT; LEUKOCYTES; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; PHENOTYPE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 67649210074     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.139     Document Type: Article

References (25)

1. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69:89-95.
2. Altar CA. The biomarkers consortium: on the critical path of drug discovery. Clin Pharmacol Ther 2008;83:361-4.
3. Vittorini S, Clerico A. Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice. Clin Chem Lab Med 2008;46:748-63.
4. Harrison JH Jr. Introduction to the mining of clinical data. Clin Lab Med 2008;28:1-7, v.
5. Post AR, Harrison JH Jr. Temporal data mining. Clin Lab Med 2008;28:83-100, vii.
6. Arana A, Rivero E, Egberts T. What do we show and who does so? An analysis of the abstracts presented at the 19th ICPE. Pharmacoepidemiol Drug Saf 2004;13:S330-1.
7. Lawrenson R, Williams T, Farmer R. Clinical information for research; the use of general practice databases. J Public Health Med 1999;21:299-304.
8. Valet G. Predictive medicine by cytomics: potential and challenges. J Biol Regul Homeost Agents 2002;16:164-7.
9. Valet G. Cytomics as a new potential for drug discovery. Drug Discov Today 2006;11:785-91.
10. Ten Berg MJ, Huisman A, van den Bemt PM, Schobben AF, Egberts AC, van Solinge WW. Linking laboratory and medication data: new opportunities for pharmacoepidemiological research. Clin Chem Lab Med 2007;45: 13-9.
11. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006;368:804-13.
12. Wardlaw AJ, Silverman M, Siva R, Pavord ID, Green R. Multi-dimensional phenotyping: towards a new taxonomy for airway disease. Clin Exp Allergy 2005;35:1254-62.
13. National Heart Lung and Blood Institute: Global Initiative for Asthma, editor. Global strategy for asthma management and prevention. NHLBI/WHO Workshop report. Bethesda: NIH Publication No. 02-3659; Updated 2007.
14. Wenzel S, Fahy J, Irvin C, Peters S, Spector S, Szefler S. Proceedings of the ATS workshop on refractory asthma. Current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 2000; 162:2341-51.
15. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung K, Barnes P. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999;160:1532-9.
16. Nguyen LT, Lim S, Oates T, Chung KF. Increase in airway neutrophils after oral but not inhaled corticosteroid therapy in mild asthma. Respir Med 2005;99:200-7.
17. Shannon J, Ernst P, Yamauchi Y, Olivenstein R, Lemiere C, Foley S, et al. Differences in airway cytokine profile in severe asthma compared to moderate asthma. Chest 2008;133:420-6.
18. Nirmala R, Narayanan P. Flowcyotmetry - a rapid tool to correlate functional activities of human peripheral blood lymphocytes with their corresponding phenotypes after in vitro stimulation. BMC Immunol 2002;3:9.
19. Kinhult J, Egesten A, Uddman R, Cardell L. PACAP enhances the expression of CD11b, CD66b and CD63 in human neutrophils. Peptides 2002;23:1735-9.
20. Subira D, Font P, Villalon L, Serrano C, Askari E, Gongora E, et al. Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders? Transl Res 2008;151: 240-5.
21. Sanchez-Margalet V, Cubero JM, Martin-Romero C, Cubero J, Cruz-Fernandez JM, Goberna R. Expression of activation molecules in neutrophils, monocytes and lymphocytes from patients with unstable angina treated with stent implantation. Clin Chem Lab Med 2004;42: 273-8.
22. Pronk-Admiraal CJ, van Haaster FE, Bartels PC. Clinical evaluation of changes in the morphology of eosinophils. Clin Chem Lab Med 2002;40:27-31.
23. Chaves F, Tierno B, Xu D. Neutrophil volume distribution width: a new automated hematological parameter for acute infection. Arch Pathol Lab Med 2006;130:378-80.
24. Karo O, Wahl A, Nicol SB, Brachert J, Lambrecht B, Spengler HP, et al. Bacteria detection by flow cytometry. Clin Chem Lab Med 2008;46:947-53.
25. Kunz D, Kunz WS, Scott CS, Gressner AM. Automated CD61 immunoplatelet analysis of thrombocytopenic samples. Br J Haematol 2001;112:584-92.